Technology | December 18, 2013

Mobius3D Version 1.3 Introduces Patient-Specific QA for Radiation Therapy Systems

MobiusFX add-on allows users to complete IMRT/VMAT QA in as little as one minute

radiation therapy qa systems accesories mobius mobius3d mobiusfx
December 18, 2013 — Mobius Medical Systems LP announced the release of the latest version of its flagship software product Mobius3D. Features of version 1.3 include the new MobiusFX add-on, which provides clinicians with a better way to perform patient-specific QA. MobiusFX utilizes linear accelerator log files and Mobius3D’s independently developed collapsed-cone algorithm to determine the 3-D dose a patient will receive. The MobiusFX technique only requires enough time to deliver the beams, which can be as quick as one minute. This allows QA to be easily achieved during breaks between patients or over a lunch hour.
As the only true 3-D solution for patient specific QA, MobiusFX can also provide information that is not available from 2-D or quasi-3-D systems. Using DVH objectives from both Radiation Therapy Oncology Group (RTOG) protocols and Task Group 101, or an unlimited number of user-defined parameters, MobiusFX lets clinicians know whether their treatments are meeting protocols. Additionally, data from the machine delivery is compared to expected positions from the treatment planning system patient plan. This provides users confidence that all parameters were correctly transferred between the TPS and the linear accelerator. Moreover, MobiusFX is not just for pre-treatment checks, as QA can easily be performed with the patient in place, opening up the possibility of per-fraction verifications.
At the core of MobiusFX is Mobius3D, the first 3-D TPS and plan check system that works with all major linear accelerators (with support for Tomotherapy plan checks coming soon). Mobius3D offers features and benefits not available in basic MU software. Full 3-D dose calculations are performed using the patient computed tomography (CT). Dose-volume histogram (DVH) objectives, plan deliverability, gantry clearance and contouring errors are calculated and examined automatically. Mobius3D’s browser-based interface can be accessed with any modern browser, including tablets and smartphones, making it easy to evaluate results from both Mobius3D and MobiusFX.
For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init